We look forward to deep-diving into your research at the congress and building a brighter future for transplant patients, together.
#ESOTcongress
Thank you to all of our abstract submitters
Category: All
ESOT joins the EU Health Coalition
We look forward to working closely with the Coalition and its 45 partners in delivering actionable change and innovation in healthcare in the future.
Abstract Submission will close on Sunday, 12 February at 23:59
Abstract Submissions for ESOT Congress 2023 and EDTCO Congress, definitely close on Sunday, 12 February at 23:59 Central European Time
DEADLINE EXTENDED!
After receiving a number of requests for extra time to submit abstracts, we’re happy to announce that we’ve extended the deadline for abstract submissions for the ESOT Congress in Athens. The extended deadline is now Saturday, 11 February (23:59 CET). This means you still have time to submit your abstract and are still eligible to
Transplant International in 2022: a review
In this news item, we wish to highlight the articles published in Transplant International in 2022 that have received the most attention, congratulate their authors and thank them for their contributions.
Live from the Fireside Chat on #ESOTcongress
If you missed the Fireside Chat on #ESOTcongress you can rewatch it here 😃 Play your part in transforming the future of transplantation by submitting an abstract before 1 February!
Submit your abstract before 1 February!
The ESOT Congress is the most influential and major event of its kind, with participants attending from all over the globe to discuss, debate and explore the latest trends in the world of transplantation. And YOU can be part of it by submitting an abstract! Present and discuss your latest research with like-minded peers, experts and international
Transplant Therapeutics Consortium’s iBox Scoring System becomes first EMA-qualified endpoint for transplant
C-Path’s Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System
The iBox Scoring System is available for use in kidney transplant clinical trials as a novel secondary endpoint prognostic for allograft loss.
A Better Future for Health in Europe – A report from the #EHFG2022
Luciano Potena confirms ESOT’s commitment to making a lasting improvement to patient outcomes, by breaking down silos and engaging with policymakers and stakeholders, and also informing them on the issues at stake.
Congratulations to our grant recipients
Congratulations to our ESOT Grant Programme 2023 recipients, who were announced at our Council meeting this month. Our Grant Programme aims to promote the education and career development of European transplant professionals. By visiting European transplant centres and participating in ESOT education programmes, participants are provided with state-of-the-art opportunities for scientific exchange and collaboration. Applications
